In The News

Gain-of-Function Risk Is Not One-Size-Fits-All

Think Global Health

September 29, 2023

In their op-ed featured in Think Global Health, CSET's Steph Batalis and Caroline Schuerger provide expert analysis on the ongoing debate in the United States regarding gain-of-function (GOF) research.

Read the Full Op-Ed

CSET’s Steph Batalis and Caroline Schuerger shared their expert analysis in an op-ed published by Think Global Health. In their piece, they discuss the ongoing debate in the United States regarding gain-of-function (GOF) research, which involves adding biological functions to pathogens like viruses or bacteria. Policymakers are considering restrictions on such research due to its potential risks, especially in the context of the COVID-19 pandemic.

Read the full op-ed in Think Global Health.

Related Content

Analysis

Understanding the Global Gain-of-Function Research Landscape

 August 2023

Gain- and loss-of-function research have contributed to breakthroughs in vaccine development, genetic research, and gene therapy. At the same time, a subset of gain- and loss-of-function studies involve high-risk, highly virulent pathogens that could spread… Read More

Steph Batalis

 August 2022

Stephanie Batalis is a Research Fellow focused on biotechnology. Read More

Caroline Schuerger

 August 2021

Caroline Schuerger was a Research Fellow at Georgetown’s Center for Security and Emerging Technology (CSET), where she focuses on emerging issues in biotechnology and AI. Prior to joining CSET, Caroline earned her PhD in Molecular… Read More